Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract (1-13). GISTs most commonly arise in the stomach (51%), and affect to a much lesManuscript received: 23.07.2010 Accepted: 07.01.2011 Turk J Gastroenterol 2011 22 (4): 363-368 doi: 10.4318/tjg.2011 
INTRODUCTION
ser extent the remaining parts of the gastrointestinal tract as follows: small intestine (36%), colon (7%), rectum (1%), or esophagus (1%).
Most GISTs are immunoreactive for CD 117 (c-kit) and CD 34, and are typically negative for S-100 protein and desmin (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . CD 117 positivity is present in all histological variants including benign and malignant GISTs of different sites. There are only a few reports stating that a small number of GISTs might be negative for CD 117 (12, 13) . It is known that Ki-67 (MIB-1) expression in a GIST of more than 10% likely indicates poor prognosis (2, 9) .
Tumor progression is characterized by both the loss of cell-cell and cell-matrix interactions as well as the invasion of the surrounding tissues by tumor cells. All cells are capable of organizing their protoplasmic actin filaments into cross-linked structures that influence cell shape, proliferation, adhesion, motility, and intracellular signaling pathway. Numerous actin-bundling proteins have been described, such as villin, fimbrin, ezrin, spectrin, filamin, and fascin (15) (16) (17) .
Fascin is a 55 kDa cross-linking protein that localizes the core actin bundles of spikes and filopodia at the leading edge of migratory cells (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Fascin promotes the formation of tightly packed parallel bundles with F-actin (16, 19, 21) . There are three forms of fascin: fascin-1 (also known as fascin), fascin-2 (retinal fascin) and fascin-3 (testicular fascin) (16, 19, 21) . Fascin has a role in the organization of actin-based structures that function in cell-cell and cell-matrix interactions and motility. Fascin binds beta-catenin, a molecule that is not only an important part of the cell-cell interaction, but also a major signaling molecule in the Wnt pathway (15) . It has been proposed that fascin might be expected to behave like an anti-oncogene because of its reducing effect on the cytoplasmic pool of soluble beta-catenin (15) . Fascin is expressed in normal mesenchymal, endothelial, dendritic, and neuronal cells, but not in normal simple columnar epithelia of the biliary duct, breast, colon, ovary, pancreas, and stomach epithelia (16, 19) . The expression of fascin in epithelial neoplasms, on the other hand, has recently been described. In normal epithelial cells, fascin expression is usually present in a very low amount but is often upregulated in several types of human neoplasms, such as ovarian, breast, pancreatic, lung, skin, colon, stomach, and esophagus tumors (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . It is not yet known how and why fascin is upregulated in carcinoma cells. Additionally, it is not clear whether the increased fascin protein expression by carcinomas is related to transcriptional or posttranscriptional events, or if the same mechanism is involved in carcinomas of different organs (19) .
There are a limited number of studies regarding the role of fascin expression in spindle cell tumors (31) . While fascin was evaluated as a potential marker of dendritic cell neoplasms, it does not seem to be a useful marker in the diagnosis of other spindle cell tumors (31) . We aimed to investigate fascin expression with regard to anatomic localizations, tumor invasiveness, prognostic risk groups, and predominant morphological features or cell types of GISTs.
MATERIALS AND METHODS
A total of 30 GIST cases diagnosed from the resection materials between 1995 and 2008 were retrieved from the archives of the Department of Pathology, Gülhane Military Medical Academy. Our cases were categorized into groups as follows: 6 cases, very low risk; 2 cases, low risk; 4 cases, moderate risk; and 18 cases, high risk ( Table 1 ). The rates of metastases or tumor-related death in GISTs were grouped by Miettinen and Lasota (7) classification according to tumor location, tumor size and mitotic rate. The distribution of our cases according to this new classification is demonstrated in Table 2 .
In order to check and confirm the diagnosis of GIST, an immunohistochemical panel consisting of six antibodies against CD 117, CD 34, smooth muscle actin (SMA), desmin, S-100 protein, and Ki-67 was performed on all cases, and reassessed by one of the participants (A.Ö.) (10) . The most suitable paraffin block for fascin immunostaining (FCN01; 1: 100 dilution; NeoMarkers, Fremont, CA, USA) was selected by reexamining 3-15 hematoxylin-eosin (H&E)-stained slides. For demonstrating the fascin expression, standard 5-μm sections were obtained and deparaffinized with xylene and rehydrated in graded alcohols. Positive cases logy. These are the most helpful clues for distinguishing them from stained tumor cells ( Figure 1 ).
Either endothelial or dendritic cells in the samples were used as internal positive controls [4] . Nonimmune serum was used as the negative control.
The differences between groups were investigated for statistical significance by the chi-square test, with p<0.05 as the cut-off point.
RESULTS
Fascin expression was noted in 17% (5/30) of the cases. All of the fascin-expressing GISTs were in the high-risk group (5/16), while the remaining high-risk as well as low-and moderate-risk GISTs showed no convincing immunoreactivity. The degree of staining was either moderate or strong (Figure 2). According to the basic four-level risk gro- ups (Table 1) and eight-level groups based on the rates of metastases or tumor-related death (Table  2) , the results seemed not statistically significant (p=0.261 and p=0.242, respectively).
Fascin expression in GISTs composed of purely spindle cells was 4.5% (1/22) ( Table 3) . On the other hand, expression in the tumors composed of both spindle and epithelioid cells was around 50% (4/8) ( Table 3) . We observed that the intensity of staining was especially more conspicuous in epithelioid cells when compared to spindle cells. This finding seemed statistically significant (p=0.003). We also noted that the epithelioid cells, when present, were almost always positively labelled by fascin antibody (Figure 3 ).
Fascin expression rates with respect to the localization of individual tumors are presented in Tables 1 and 2. No fascin expression was detected in GISTs from the large bowel (rectum) (0/3). We noticed a tendency of higher level of expression in the small bowel (jejunum and duodenum)-derived GISTs than those from the other localizations, and the difference was also statistically significant (p=0.043).
All the five fascin-positive tumors were demonstrated to have some extent of infiltration into the nearby soft tissues and/or organs. One of the jejunal cases showed recurrence just six months after the primary surgical removal of the tumor.
While epithelioid tumor cells were mostly positive for SMA as well, no immunoreactivity in spindle cells was detected. All fascin-positive cases were found negative for MSA.
DISCUSSION
Most of the gastrointestinal mesenchymal tumors, previously diagnosed as smooth muscle tumors, are now classified as GISTs. GISTs have a potential to show a wide variety of phenotypic differentiation including myoid, neural, mixed, and null morphology. Therefore, a broad immunohistochemical panel including muscular and neural markers such as CD 117 (c-kit), CD 34, SMA, desmin, and S-100 protein are required in their differential diagnosis. GISTs are usually positive for CD 117 (c-kit) and negative for S-100 and desmin (3, (5) (6) (7) 13) . A small percentage of CD 117-negative GISTs are known to be positive for platelet-derived growth factor receptor-alpha (PDGFR-A), a receptor tyrosine kinase similar to CD 117 (5-7). Approximately 60-99% of all GISTs are also positive for CD 34, which is a progenitor-cell antigen mainly expressed by endothelial cells and in some subsets of fibroblasts and their tumors (6, 7, 13) . About 10-30% of GISTs show a malignant clinical course (6) . Pathologically, tumor location, size and mitotic activity are independent prognostic factors for GISTs (3, 5) .
Fascin is an actin-bundling protein that is expressed in normal mesenchymal, endothelial, dendritic, and neuronal cells but not in normal epithelia (16) . Many types of transformed epithelial cell lines and several epithelial tumors have been shown to express fascin (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Some studies have suggested that the degree of fascin expression is well correlated with tumor stage, grade, lymph node involvement, and recurrence rate (22, 23, 29) . However, this kind of relationship of fascin expression in spindle cell tumors has not yet been very well evaluated or documented. Grogg et al. (31) suggested that fascin is a potentially important marker for dendritic cell neoplasms, but it does not seem to be a useful marker in the diagnosis of other spindle cell tumors. In this study, we investigated the fascin expression in GISTs against their anatomic locations, invasiveness, prognostic risk groups, and the predominant morphology of neoplastic cells, either epithelioid, spindle or mixed. In summary, our results indicated that the fascin expression was mostly moderate and limited only in high-risk GISTs. The other risk groups of GISTs showed practically no immunoreactivity with fascin. Staining intensity of epithelioid cells was significantly higher than that of the spindle cells. We noticed a tendency of higher level of expression in the small bowel (duodenum and jejunum) GISTs than those from the other localizations. These findings suggest that fascin expression in GISTs might be a well-correlated marker with the risk groups that are related to the tumor progression and aggressiveness.
